Therapeutic Serum Lithium Concentration
The therapeutic serum lithium concentration range is 0.6-1.2 mEq/L for maintenance treatment, with acute mania requiring higher levels of 1.0-1.5 mEq/L. 1
Acute Mania Treatment
For acute manic episodes, target serum lithium levels between 1.0-1.5 mEq/L 1. This typically requires dosing of 600 mg three times daily, though individual titration based on serum levels and clinical response is essential. During the acute phase, monitor serum levels twice weekly until both the level and clinical condition stabilize 2.
Maintenance/Long-term Control
Once stabilized, the target range drops to 0.6-1.2 mEq/L 1. Most patients achieve this with 300 mg three or four times daily. The FDA label specifies this as the "desirable" range for long-term control, and this aligns with guideline recommendations for monitoring every 3-6 months during stable maintenance therapy 2.
Evidence-Based Refinements
Recent high-quality research provides important nuance to these FDA ranges:
Standard maintenance dosing (0.8-1.0 mmol/L) is significantly more effective than lower dosing (0.4-0.6 mmol/L), with 2.6 times lower relapse risk, though at the cost of increased side effects including tremor, diarrhea, urinary frequency, and weight gain 3
The ISBD/IGSLI Task Force consensus recommends 0.6-0.8 mmol/L as the standard for most adults, with flexibility to reduce to 0.4-0.6 mmol/L for good responders with poor tolerance, or increase to 0.8-1.0 mmol/L for insufficient response with good tolerance 4
Critical Monitoring Parameters
Timing of blood draws matters critically: Always draw samples 8-12 hours after the previous dose when concentrations are relatively stable 1. This is typically a morning trough level before the first daily dose.
Baseline Requirements Before Starting Lithium
- Complete blood count
- Thyroid function tests (TSH, free T4)
- Urinalysis
- BUN and creatinine
- Serum calcium
- Pregnancy test in females of childbearing age 2
Ongoing Monitoring Schedule
Once stable on lithium:
- Serum lithium levels every 3-6 months 2
- Renal function (BUN, creatinine) every 3-6 months
- Thyroid function every 3-6 months
- Urinalysis every 3-6 months
Age-Specific Considerations
Elderly patients (≥65 years) often require lower targets and exhibit toxicity at levels tolerated by younger patients 1. Consider targeting 0.4-0.6 mmol/L in this population, with maximum levels of 0.7-0.8 mmol/L for ages 65-79 and 0.7 mmol/L maximum over age 80 5.
Children and adolescents lack clear consensus, though the same adult ranges are often applied with careful monitoring 4.
Toxicity Thresholds
Patients abnormally sensitive to lithium may show toxic signs at 1.0-1.5 mEq/L 1. Levels ≥1.4 mmol/L represent frank toxicity requiring urgent intervention 6. Real-world data shows 6.1% of monitored levels fall above the therapeutic range, with 1.0% at dangerous levels ≥1.4 mmol/L 6.
Common Pitfalls
Do not rely solely on serum levels—accurate patient evaluation requires both clinical assessment and laboratory analysis 1. Symptoms of toxicity (coarse tremor, confusion, ataxia, dysarthria) may appear before levels reach classically "toxic" ranges in vulnerable patients.
Subtherapeutic dosing is common: Real-world data shows 19.2% of lithium levels fall below the therapeutic range, with many patients maintained at the lower end (median 0.60 mmol/L) 6. While this may reduce side effects, it significantly increases relapse risk 3.